IR@PKUHSC  > 北京大学药学院
学科主题药学
Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals
Hao, Leilei1; Wang, Xiaoyong2; Zhang, Dianrui1; Xu, Qingyan2; Song, Siyang2; Wang, Feihu1; Li, Caiyun1; Guo, Hejian1; Liu, Yue1; Zheng, Dandan1; Zhang, Qiang3
关键词Amoitone b Nanocrystals Microfluidization Method In Vitro Dissolution Pharmacokinetics
刊名INTERNATIONAL JOURNAL OF PHARMACEUTICS
2012-08-20
DOI10.1016/j.ijpharm.2012.05.002
433期:1-2页:157-164
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
资助者National Basic Research Program of China (973Program) ; National Basic Research Program of China (973Program)
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]POORLY SOLUBLE DRUGS ; ORPHAN-RECEPTOR NUR77 ; CANCER CELLS ; TISSUE DISTRIBUTION ; ORAL BIOAVAILABILITY ; PROAPOPTOTIC GENES ; NUCLEAR RECEPTORS ; DELIVERY-SYSTEM ; PARTICLE-SIZE ; IN-VIVO
英文摘要

Amoitone B, as a new derivative of cytosporone B, has been proved to be a natural agonist for Nur77. It exhibits remarkable anticancer activity in vivo and has the potential to be a therapeutic agent for cancer treatment. However, the poor solubility and dissolution rate result in low therapeutic index for injection and low bioavailability for oral administration, therefore limiting its application. In order to magnify the clinical use of Amoitone B, nanocrystal was selected as an application technology to solve the above problems. In this study, the optimized Amoitone B nanocrystals with small and uniform particle size were successfully prepared by microfluidization method and investigated by morphology, size distribution, and zeta potential. The differential scanning calorimetry (DSC) and X-ray diffraction (XRD) confirmed there was no crystalline state changed in the size reduction process. For Amoitone B nanocrystals, an accelerated dissolution velocity and increased saturation solubility were achieved in vitro and a markedly different pharmacokinetic property in vivo was exhibited with retarded clearance and magnified AUC compared with Amoitone B solution. These results implied that developing Amoitone B as nanocrystals is a promising choice for intravenous delivery and further application for cancer therapy. (C) 2012 Elsevier B. V. All rights reserved.

语种英语
所属项目编号2009CB930300
资助者National Basic Research Program of China (973Program) ; National Basic Research Program of China (973Program)
WOS记录号WOS:000305420100020
Citation statistics
Cited Times:32[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/50464
Collection北京大学药学院
作者单位1.Shandong Univ, Dept Pharmaceut, Coll Pharm, Jinan 250012, Peoples R China
2.Xiamen Univ, State Key Lab Stress Cellular Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China
3.Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
Recommended Citation
GB/T 7714
Hao, Leilei,Wang, Xiaoyong,Zhang, Dianrui,et al. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS,2012,433(1-2):157-164.
APA Hao, Leilei.,Wang, Xiaoyong.,Zhang, Dianrui.,Xu, Qingyan.,Song, Siyang.,...&Zhang, Qiang.(2012).Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals.INTERNATIONAL JOURNAL OF PHARMACEUTICS,433(1-2),157-164.
MLA Hao, Leilei,et al."Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals".INTERNATIONAL JOURNAL OF PHARMACEUTICS 433.1-2(2012):157-164.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Hao, Leilei]'s Articles
[Wang, Xiaoyong]'s Articles
[Zhang, Dianrui]'s Articles
百度学术
百度学术Similar articles in
[Hao, Leilei]'s Articles
[Wang, Xiaoyong]'s Articles
[Zhang, Dianrui]'s Articles
必应学术
必应学术Similar articles in
[Hao, Leilei]'s Articles
[Wang, Xiaoyong]'s Articles
[Zhang, Dianrui]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.